GSK and Vir Biotechnology announce US government agreement to purchase additional supply of sotrovimab, authorised for the early treatment of COVID-19
We use cookies to give you the best experience. By continuing to use this site you consent to the use of cookies, unless disabled from your browser. OkPrivacy policy